Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2014
06/19/2014WO2014090692A1 Novel bi-ring phenyl-pyridines/pyrazines for the treatment of cancer
06/19/2014WO2014089913A1 Bicyclic compound functioning as tyrosine kinase inhibitor
06/19/2014US20140171639 Trpm8 antagonists and their use in treatments
06/19/2014US20140171456 FUSED TRICYCLIC COMPOUNDS AS mTOR INHIBITORS
06/19/2014US20140171454 Substituted Pyrrolo[2,3-d]pyrimidines as Inhibitors of Protein Kinases
06/19/2014US20140171453 Inhibitors of bruton's tyrosine kinase
06/19/2014US20140171435 Chemical Compounds
06/19/2014US20140171434 Substituted imidazopyridines and imidazopyridazines and the use thereof
06/19/2014US20140171430 Disubstituted octahydropyrrolo [3,4-c] pyrroles as orexin receptor modulators
06/19/2014US20140171423 Agents for treating pain and uses thereof
06/19/2014US20140171422 Pyrimidodiazepinone compound
06/19/2014US20140171420 Diazole lactams
06/19/2014US20140171417 Tricyclic compounds
06/19/2014US20140171414 Novel compounds
06/19/2014US20140171412 Tricyclic compounds
06/19/2014US20140171409 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
06/19/2014US20140171406 Trpm8 antagonists and their use in treatments
06/19/2014US20140171405 Fused Pyrazoles as FGFR Inhibitors
06/19/2014US20140171392 Use of an Adrenal Hormone-Modifying Agent
06/19/2014US20140171336 Methods and Kits Using Extended Rhodamine Dyes
06/19/2014US20140170111 Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
06/18/2014EP2743266A2 Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon
06/18/2014EP2742936A1 Fused heterocyclic compound and use thereof
06/18/2014EP2742049A1 Tricyclic heterocyclic compounds and jak inhibitors
06/18/2014EP2742045A1 Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1h-[1,8]naphthyridinones
06/18/2014EP2742030A1 1,2,4-triazolyl-substituted keto-enols
06/18/2014CN103874702A Novel substituted indole derivatives as gamma secretase modulators
06/18/2014CN103874699A Pyrazolo[4,3-c]pyridine derivatives as kinase inhibitors
06/18/2014CN103874698A Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1h-[1,8]naphthyridinones
06/18/2014CN103874697A Dibenzooxepin derivative
06/18/2014CN103864801A Pyrazole spiro derivatives as well as preparation method and bactericide application thereof
06/18/2014CN103864800A Synthesis method for 6-chloroimidazo[1,2-b] pyridazine
06/18/2014CN103864799A Method for synthesizing 5,6,7,8-tetrahydroimidazole-[1,2-A]-pyrazine
06/18/2014CN103864798A Deuterated estazolam and preparation method thereof
06/18/2014CN103864797A Compounds with nerve protection function and application thereof
06/18/2014CN103864796A Purification production method of pilsicainide hydrochloride
06/18/2014CN103864795A Dithiolane-containing cis-anabasine compound and preparation method and application thereof
06/18/2014CN103864794A Method for preparing ticagrelor medicine for resisting platelet aggregation
06/18/2014CN103864792A Heterocyclic nitrogen compound acting as tyrosine kinase inhibitor
06/18/2014CN103864770A Pyrimidinamine and pyridinamine Hedgehog signal conduction inhibitors
06/18/2014CN103864692A Ionic liquid and method for oil extraction using same
06/18/2014CN103864653A Compounds for reducing intraocular pressure and use thereof
06/18/2014CN103100080B Application of cGP and derivatives in preparation of medicine for inhibiting tumor growth and regeneration
06/18/2014CN102627632B Amino quinazoline derivative and preparation method as well as application thereof
06/18/2014CN102503946B Gas phase process decolorization method of methenamine mother liquor and decolorization device thereof
06/18/2014CN102452873B Compound containing carbon or oxygen isotope and preparation method thereof and application thereof and composition thereof
06/18/2014CN102372717B Pyrrolopyrimidine compound and use thereof
06/18/2014CN102307870B Pyridyloxyindoles inhibitors of VEGF-R2 and use thereof for treatment of disease
06/18/2014CN102093751B Pigment particle dispersion body, photo-curing composition and color filter using dispersion
06/18/2014CN102007124B Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases
06/18/2014CN101970396B New ruthenium complexes as catalysts for metathesis reactions
06/18/2014CN101959966B Azo compound, azo pigment, and dispersion, colored composition, ink-jet recording ink, ink-get recording ink tank, ink-jet recording method and recorded material each containing the azo compound or the azo pigment
06/18/2014CN101935323B Purification method of deuterohemin
06/17/2014US8754222 Process for preparing modulators of cystic fibrosis transmembrane conductance regulator
06/17/2014US8754211 Azolotriazinone melanin concentrating hormone receptor-1 antagonists
06/17/2014US8754190 Controlled release from macromolecular conjugates
06/17/2014US8754116 Macrocyclic inhibitors of hepatitis C virus
06/17/2014US8754107 Aminopyrrolidines as chemokine receptor antagonists
06/17/2014US8754106 Macrocyclic inhibitors of hepatitis C virus
06/17/2014US8754091 Inhibitors of bruton's tyrosine kinase
06/17/2014US8754090 Use of inhibitors of bruton's tyrosine kinase (Btk)
06/17/2014US8754078 Compositions and methods for treatment of cancer
06/17/2014US8754072 Salts and polymorphs of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
06/17/2014CA2634721C Triazolopyridazines as tyrosine kinase modulators
06/12/2014WO2014089379A1 Compounds useful as inhibitors of atr kinase
06/12/2014WO2014088315A1 Crystalline doripenem monohydrate, and method for preparing same
06/12/2014WO2014088300A1 Organic electroluminescence compounds and organic electroluminescence device comprising the same
06/12/2014WO2014087208A2 A process of preparing alcaftadine
06/12/2014WO2014086806A1 Pyridine-2-amides useful as cb2 agonists
06/12/2014WO2014086453A1 Azaheterobicyclic compounds
06/12/2014WO2014086325A1 A method of preparing 3-amino-4-(2,4,5-trifluorophenyl)butanoic acid derivatives
06/12/2014WO2014086291A1 Method for preparing ticagrelor and intermediates thereof
06/12/2014WO2014086102A1 Indole full ketone derivative used as tyrosine-kinase inhibitor
06/12/2014US20140163226 Novel pyrimidine derivative and pharmaceutical composition including same as an active ingredient
06/12/2014US20140163049 Antimicrobial Compounds and Methods of Making and Using the Same
06/12/2014US20140163046 Inhibitors of bruton's tyrosine kinase
06/12/2014US20140163033 Pyrrolotriazinone derivatives as p13k inhibitors
06/12/2014US20140163027 Inhibitors of bruton's tyrosine kinase
06/12/2014US20140163023 Dihydropyrrolo pyrimidine derivatives as mtor inhibitors
06/12/2014US20140163014 Benzodiazepine and pyridodiazepine derivatives
06/12/2014US20140163010 PYRAZOLO[3,4-d]PYRIMIDINE COMPOUNDS, THEIR PREPARATION AND USE AS SIGMA LIGANDS
06/12/2014US20140163009 Histone deacetylase inhibitors and compositions and methods of use thereof
06/12/2014US20140163008 Dibenzooxepin derivative
06/12/2014US20140163002 Cyclic p1 linkers as factor xia inhibitors
06/12/2014US20140163000 Compounds useful as inhibitors of atr kinase
06/12/2014US20140162971 Bromodomain inhibitors
06/12/2014US20140161830 Amine-containing lipidoids and uses thereof
06/12/2014CA2815506A1 Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride
06/11/2014EP2740733A1 MTOR kinase inhibitors for oncology indications and diseases associated with the MTOR/P13K/AKT pathway
06/11/2014EP2740732A1 MTOR kinase inhibitors for oncology indications and diseases associated with the MTOR/P13K/AKT pathway
06/11/2014EP2740731A1 Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
06/11/2014EP2740730A1 Dibenzooxepin derivative
06/11/2014EP2739629A1 Compounds for treating respiratory syncytial virus infections
06/11/2014EP2739628A1 Novel macrocycles as factor xia inhibitors
06/11/2014EP2739627A1 2,3-dihydroimidazo[1,2-c]pyrimidin-5(1h)-one compounds use as lp-pla² inhibitors
06/11/2014EP2739625A1 Cyclic p1 linkers as factor xia inhibitors
06/11/2014CN103857681A Novel macrocycles as factor XIA inhibitors
06/11/2014CN103857680A Novel organic electroluminescent compounds and organic electroluminescent device using the same
06/11/2014CN103857679A Methods for the preparation of 5-[2-[7-(trifluoromethyl)-5-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]-2-pyridinamine
06/11/2014CN103857678A Pyrazoline derivatives and their use as selective androgen receptor modulators
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 573